Obese rhesus monkey study
- Reported quantity
- 0.43 mg/kg body weight
- Frequency
- Once daily
- Study duration
- 28 days
Weight loss was reported alongside renal proximal tubule injury that resolved after withdrawal.
Protocols · Metabolic
Adipotide: literature-reported ranges
Adipotide was developed as an anti-obesity candidate that destroys the blood supply of white adipose tissue rather than acting on appetite. The published record is rodent and non-human primate work; the primate study reported dose-limiting renal toxicity, which is the reason no human programme followed.
Read this first
Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.
Compound at a glance
- Class
- Pro-apoptotic peptidomimetic targeting prohibitin in white adipose vasculature
- Reported half-life
- Short in plasma; reported activity is driven by vascular targeting rather than exposure time
- Routes used in the literature
- Subcutaneous and intraperitoneal in animal work
- Also written as
- FTPP, Prohibitin-targeting peptidomimetic
What the published studies reported
Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.
Rodent obesity models
- Reported quantity
- Commonly 1–3 mg/kg body weight
- Frequency
- Once daily
- Study duration
- Typically 4 weeks
Figures are per kilogram of animal body weight and are not human-equivalent values.
Mixed with 3 ml of bacteriostatic water
The same arithmetic for every vial size Adipotide is supplied in, using a fixed 3 ml of bacteriostatic water. One unit on a U-100 insulin syringe is 0.01 ml, so the unit column below is simply the volume that carries the reported amount. Educational arithmetic only — not instructions, and not medical advice.
Adipotide · 3 ml bacteriostatic water
| Vial size | Concentration | Per 1 unit |
|---|---|---|
| 2 mg | 0.67 mg/ml | 7 mcg |
| 5 mg | 1.67 mg/ml | 17 mcg |
No single reported amount applies to this compound, so only the concentration and the value of one unit are shown. Only the vial sizes this compound is actually supplied in are shown, and every figure assumes exactly 3 ml of bacteriostatic water. For any other volume, use the reconstitution calculator.
Reconstitution maths
Supplied as 2 mg and 5 mg lyophilised vials. A 5 mg vial in 3 ml of bacteriostatic water gives 1.67 mg/ml. The reconstitution calculator on this site converts any vial and volume.
Open the reconstitution calculatorHow to read these figures
- Renal toxicity is the single most reported finding in the primate literature and is not incidental to the mechanism.
- No human trial data exists — every human figure circulating online is an extrapolation.
- Reported weight loss in animals was rapid and partially reversed after dosing stopped.
Sources and citations
No peer-reviewed primary literature reporting administered quantities exists for this item. Anything circulating online about quantities is anecdote rather than evidence, and this page will not reproduce it. The database links below are kept so you can check for yourself as new work is published.
Search the databases yourself
Other metabolic compounds
AICARAMP analogue and AMPK activator (small molecule, not a peptide)CagrilintideLong-acting amylin analogue (AMY1 class)GLP1 (semaglutide / Ozempic)GLP-1 receptor agonistGLP2 (tirzepatide / Mounjaro)Dual GIP/GLP-1 receptor agonist
All research protocolsPeptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.